U.S. License Holder:
Lupin
Date of License:
aBLA accepted by FDA June-2021
Last Update:
Nov-15-2023
FDA-Approved Indications
Lupin's pegfilgrastim is not FDA-approved. An aBLA has been accepted by the FDA.